Variant:
rs4124874 at chr2:234665659 in UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9 (VIP)

Alleles (on + chromosomal strand)
T > G
Alternate Names:
UGT1A1*60, UGT1A1:-3263T>G, UGT1A1:-3279T>G, c.61-10021T>G, c.856-10021T>G, c.862-10021T>G, c.868-10021T>G, g.172270T>G, g.1741T>G, g.611918T>G

Variant Annotations

PharmGKB variant annotations provide information about variant-drug pairs based on individual PubMed publications. Each annotation represents information from a single paper and the goal is to report the information that the author states, not an interpretation of the paper. The PMID for supporting PubMed publications is found in the "Evidence" field.

Information presented, including study size, allele frequencies and statistics is taken directly from the publication. However, if the author does not correct p-values in cases of multiple hypotheses, curators may apply a Bonferroni correction. Curators attempt to report study size based on the actual number of participants used for the calculation of the association statistics, so the number may vary slightly from what is reported in the abstract of the paper. OMB Race Category information is derived from the paper and mapped to standardized categories. Category definitions may be found by clicking on the "OMB Race Category" link.

There are 2 annotations for this variant. Register or sign in to see them.

VIP Variant in UGT1A1

UGT1A1:*60
Identified in 2002 by Sugatani et al., rs4124874, -3279T>G (*60; also referred to as -3263T>G) is a common variant that is located in the Phenobarbital Response Enhancer Module (PBREM), a regulatory element positioned 3kb upstream of the UGT1A1 gene [Article:11906189]. The allele frequency of -3279T in Caucasians ranges from 0.39-0.55, while the -3279T allele frequency is much lower in the African-American population (0.15) [Articles:12464801, 15007088]. The allele frequency of -3279T in a Japanese population was estimated to be 0.83, while a Japanese population with Gilbert syndrome had a -3279T allele frequency of 0.42 [Article:11906189]. The functional significance of the -3279T>G variant requires further investigation, but genotyping of the -3279T>G variant has been proposed, in combination with the -3156G>A PBREM variant, to improve the prediction of UGT1A1 status in individuals being treated with irinotecan [Articles:15864130, 15007088, 15179405].

Key Publications:
Drugs / Other Molecules
Chemical (1)
bilirubin 9 10
Diseases Hyperbilirubinemia 11 12
Phenotype
Irinotecan toxicity 13 14
Phenotype Datasets Irinotecan Clinical Data

Appendix

gp position: chr2:234330398(hg18)
Genomic Variant & GenBank ID: 598413G>T on NT_005120

Connected Drugs

Connected Drug Classes

Connected Diseases

Publications related to rs4124874 at chr2:234665659: 5

No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes. Pharmacogenetics and genomics. 2005. Innocenti Federico, et al. [Article:15864130@PubMed]
UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer. Clinical pharmacology and therapeutics. 2004. Sai Kimie, et al. [Article:15179405@PubMed]
Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004. Innocenti Federico, et al. [Article:15007088@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochemical and biophysical research communications. 2002. Sugatani Junko, et al. [Article:11906189@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups. Pharmacogenetics. 2002. Innocenti Federico, et al. [Article:12464801@PubMed]

Cross-References

UCSC Golden Path:
chr2:234665659
dbSNP:
rs4124874
HapMap:
rs4124874

Platform Availability

  • Illumina

Common Searches

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.